Sradha Kotwal's Publications

About Sradha Kotwal's Publications

Program Head, Renal and Metabolic Division

  • Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset

    Diabetes, Obesity and Metabolism Date published:

  • Albuminuria, Kidney Function and Heart Failure Risk in Type 2 Diabetes: Participant-level pooled analysis from CANVAS Program and CREDENCE trial

    Journal of Cardiac Failure Date published:

  • Changes in Dialysis Practice Patterns in Australia and New Zealand During the COVID -19 Pandemic Period

    Nephrology Date published:

  • Prophylactic Antibiotics Before Insertion of Tunneled Hemodialysis Catheters: A Nationwide Cohort Study

    Kidney Medicine Date published:

  • Glomerular disease registry and biobank: design and baseline results

    Internal Medicine Journal Date published:

  • Assessing patterns of chronic kidney disease care in Australian primary care: a retrospective cohort study of a national general practice dataset

    The Lancet Regional Health - Western Pacific Date published:

  • Systematic Review of the Effects of Iron on Cardiovascular, Kidney, and Safety Outcomes in Patients With CKD

    Kidney International Reports Date published:

  • Variability in HbA1c and the risk of major clinical outcomes in type 2 diabetes with chronic kidney disease: Post hoc analysis from the CREDENCE trial

    Diabetes, Obesity and Metabolism Date published:

  • Effects of SGLT2 inhibition on insulin use in CKD and type 2 diabetes: insights from the CREDENCE trial

    Nephrology Dialysis Transplantation Date published:

  • Effects of Semaglutide on CKD in Patients With Type 2 Diabetes

    Kidney International Reports Date published:

  • Risk factors associated with 30-day mortality following COVID -19 infection in patients receiving kidney replacement therapy in Australia and New Zealand

    Internal Medicine Journal Date published:

  • Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial

    Diabetes, Obesity and Metabolism Date published:

  • Characterising the Contemporary Haemodialysis Population in Fiji

    Date published:

  • Sex Disparities in Receiving Medications in a Global Cohort of Patients With Chronic Kidney Disease

    Date published:

  • Prevalence of Cardiova scular-Kidney-Metabolic Multimorbidity in Australian Primary Care: Estimates From A National General Practice Dataset

    Date published:

  • Eye on AKI: Are Shifting Trends the Cue for a Platform Clinical Trial?

    Journal of the American Society of Nephrology Date published: